STATE STREET CORP - ARGOS THERAPEUTICS INC ownership

ARGOS THERAPEUTICS INC's ticker is ARGSXXXX and the CUSIP is 040221103. A total of 37 filers reported holding ARGOS THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.01 and the average weighting 0.5%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of ARGOS THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$1,000
-50.0%
11,9000.0%0.00%
Q3 2017$2,000
-50.0%
11,9000.0%0.00%
Q2 2017$4,000
-95.1%
11,900
-93.5%
0.00%
Q1 2017$82,000
-90.6%
184,194
+3.8%
0.00%
Q4 2016$870,000
+10.5%
177,494
+11.7%
0.00%
Q3 2016$787,000
+6.2%
158,869
+31.3%
0.00%
Q2 2016$741,000
+179.6%
120,996
+356.5%
0.00%
Q1 2014$265,00026,5070.00%
Other shareholders
ARGOS THERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
SANDERS MORRIS HARRIS LLC 241,512$1,201,0000.36%
WALL STREET ASSOCIATES 185,097$920,0000.31%
WASATCH ADVISORS LP 3,228,741$16,047,0000.24%
ALTRINSIC GLOBAL ADVISORS LLC 172,505$857,0000.03%
Dynamic Technology Lab Private Ltd 19,007$94,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 121,524$604,0000.01%
Alyeska Investment Group, L.P. 200,000$994,0000.01%
Acrospire Investment Management LLC 2,100$10,0000.01%
Alyeska Investment Group, L.P. 111,424$554,0000.01%
Advisor Group, Inc. 13,500$67,0000.00%
View complete list of ARGOS THERAPEUTICS INC shareholders